RESET: Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools

Sponsor
H. Lee Moffitt Cancer Center and Research Institute (Other)
Overall Status
Recruiting
CT.gov ID
NCT04335799
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (NIH)
340
1
2
43.1
7.9

Study Details

Study Description

Brief Summary

The purpose of this protocol is to test the effects on weight of an evidence-based behavioral weight loss program enhanced with culturally targeted stress management strategies compared to the evidence-based weight loss program alone among adult black females with obesity and elevated stress levels. Participants will be randomized to receive either a behavioral weight loss intervention with a focus on stress management or the weight loss intervention alone for 26 sessions.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Diabetes Prevention Program Intensive Lifestyle Intervention plus stress management training
  • Behavioral: Diabetes Prevention Program Intensive Lifestyle Intervention plus general women's health topics
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
340 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Improving Weight Loss Outcomes of Black Women Using a Culturally-Relevant Stress-Management Enhanced Behavioral Weight Loss Intervention
Actual Study Start Date :
Oct 29, 2021
Anticipated Primary Completion Date :
Jan 1, 2025
Anticipated Study Completion Date :
Jun 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Weight Loss Plus Stress Management

Diabetes Prevention Program Intensive Lifestyle Intervention augmented with stress management training

Behavioral: Diabetes Prevention Program Intensive Lifestyle Intervention plus stress management training
12-month evidence based weight loss intervention with additional training on stress management strategies

Active Comparator: Weight Loss Only

Diabetes Prevention Program Intensive Lifestyle Intervention plus general women's health topics

Behavioral: Diabetes Prevention Program Intensive Lifestyle Intervention plus general women's health topics
12-month evidence based weight loss intervention with an attention control of general women's health topics

Outcome Measures

Primary Outcome Measures

  1. 4-month mean weight change of participants using SECA scale [Baseline to Month 4]

    weight change as measured by a SECA scale in kilograms and baseline and month 4 will be calculated and averaged

  2. 12-month mean weight change of participants using SECA scale [Baseline to Month 12]

    weight change as measure by a SECA scale in kilograms and baseline and month 12 will be calculated and averaged

Secondary Outcome Measures

  1. mean change in perceived stress using Perceived Stress Scale-10 score [Baseline to Month 4]

    Perceived stress as measured with a validated survey will be assessed at baseline and month to assess changes in participant's stress

  2. mean change in perceived stress using Perceived Stress Scale-10 score [Baseline to Month 12]

    Perceived stress as measured with a validated survey will be assessed at baseline and month 12 to assess changes in participant's stress

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 75 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • BMI of at least 30 kg/m^2

  • elevated stress levels based on perceived stress scale score

  • self-identified as black race

Exclusion Criteria:
  • pregnant or are planning to become pregnant in the next year

  • known major medical or psychological condition known to influence body weight loss (e.g., medicated or poorly controlled diabetes (fasting blood glucose > 126 mg/dL), cardiovascular event in the preceding 12 months, history of gastric bypass surgery, bariatric surgery, or eating disorder)

  • history of psychiatric hospitalization in past 2 years

  • history of substance abuse or eating disorder

  • any condition for which a medical professional has suggested diet modification, physical activity, and/or weight reduction would be contraindicated.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Moffitt Cancer Center Tampa Florida United States 33612

Sponsors and Collaborators

  • H. Lee Moffitt Cancer Center and Research Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators

  • Principal Investigator: Tiffany L Carson, PhD, Moffitt Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov Identifier:
NCT04335799
Other Study ID Numbers:
  • MCC-21236
  • R01DK125367
First Posted:
Apr 6, 2020
Last Update Posted:
Aug 17, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 17, 2022